- We could reduce reliance on antibiotics through the use of advanced biomaterials?
- We could regenerate worn out or torn cartilage using only biodegradable biomaterials?
- We could create more devices that could be surgically inserted using minimally invasive techniques?
- We can improve the manufacturing process of currently used biomaterials?
Medical technology has a turnover in excess of £16 billion.
Novel medical approaches to improve human health and well-being are essential for maintaining the UK’s internationally leading position in medical technology. A new generation of “smart” biomaterials is required.
The Biomedical Materials is a key theme within the Henry Royce Institute and intends to accelerate the discovery, manufacture and translation of biomaterials through a platform of state-of-the-art equipment.
The two identified grand challenges of advanced biomaterials research are restoring biological function with minimal invasiveness (e.g. regenerative medicine, novel prosthetics and implants) and developing new therapies that reduce patient risk, improve efficacy, and lower cost (e.g. nanomedicine theranostics and personalised medicine).
This theme will deliver:
- Direct patient benefit by replacement of damaged tissues
- 3D in vitro tissues for improved pharmaceutical testing
- Significantly reduce the need for animal testing.
- Reduce the overall cost of production of medical devices
- Global impact in terms of healthcare provision
The University of Manchester, working with Sheffield